Incidence of hypercoagulable events after image-guided percutaneous cryoablation of renal tumors: A single-center experience

Journal of Vascular and Interventional Radiology

Volumn 25, Issue 5, 2014, Pages 776-779

  Hartman, Jason B ^b   Bhojwani, Nicholas ^a   Corn, David J ^a   Cooney, Matthew M ^a   Haaga, John ^a   Ponsky, Lee ^a   Abouassaly, Robert ^a   Paspulati, Akshay ^c   Prologo, J David ^d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d Centers for Dialysis Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; FEMALE; HUMAN; HYPERCOAGULABILITY; IMAGE GUIDED PERCUTANEOUS RENAL CRYOABLATION; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; THROMBOSIS; VERY ELDERLY; COMORBIDITY; COMPARATIVE STUDY; COMPUTER ASSISTED SURGERY; CRYOSURGERY; EPIDEMIOLOGY; KIDNEY NEOPLASMS; MIDDLE AGED; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; RADIOGRAPHY; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; CAUSALITY; COMORBIDITY; CRYOSURGERY; FEMALE; HUMANS; INCIDENCE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; OHIO; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SURGERY, COMPUTER-ASSISTED; THROMBOSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84899069523     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2014.01.027     Document Type: Article

References (25)

1. G. Gravante, G. Sconocchia, S.L. Ong, A.R. Dennison, and D.M. Lloyd Immunoregulatory effects of liver ablation therapies for the treatment of primary and metastatic liver malignancies Liver Int 29 2009 18 24
2. W.C. Chapman, J.P. Debelak, and C. Wright Pinson et al. Hepatic cryoablation, but not radiofrequency ablation, results in lung inflammation Ann Surg 231 2000 752 761
3. K.K. Ng, C.M. Lam, and R.T. Poon et al. Comparison of systemic responses of radiofrequency ablation, cryotherapy, and surgical resection in a porcine liver model Ann Surg Oncol 11 2004 650 657
4. T.S. Blackwell, J.P. Debelak, and A. Venkatakrishnan et al. Acute lung injury after hepatic cryoablation: correlation with NF-kappa B activation and cytokine production Surgery 126 1999 518 526
5. Y. Yang, C. Wang, and Y. Lu et al. Outcomes of ultrasound-guided percutaneous argon-helium cryoablation of hepatocellular carcinoma J Hepatobiliary Pancreat Sci 19 2012 674 684
6. M.C. Jansen, R. van Hillegersberg, and I.G. Schoots et al. Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model Surgery 147 2010 686 695
7. W.A. Soanes, R.J. Ablin, and M.J. Gonder Remission of metastatic lesions following cryosurgery in prostatic cancer: immunologic considerations J Urol 104 1970 154 159
8. M.H. Ravindranath, T.F. Wood, and D. Soh et al. Cryosurgical ablation of liver tumors in colon cancer patients increases the serum total ganglioside level and then selectively augments antiganglioside IgM Cryobiology 45 2002 10 21
9. J.K. Seifert, and D.L. Morris World survey on the complications of hepatic and prostate cryotherapy World J Surg 23 1999 109 113 discussion 113-104
10. K. Littlewood Anesthetic considerations for hepatic cryotherapy Semin Surg Oncol 14 1998 116 121
11. T.D. Atwell, R.E. Carter, and G.D. Schmit et al. Complications following 573 percutaneous renal radiofrequency and cryoablation procedures J Vasc Interv Radiol 23 2012 48 54
12. C.S. Georgiades, K. Hong, C. Bizzell, J.F. Geschwind, and R. Rodriguez Safety and efficacy of CT-guided percutaneous cryoablation for renal cell carcinoma J Vasc Interv Radiol 19 2008 1302 1310
13. W.C. Chapman, J.P. Debelak, and T.S. Blackwell et al. Hepatic cryoablation-induced acute lung injury: pulmonary hemodynamic and permeability effects in a sheep model Arch Surg 135 2000 667 672 discussion 672-663
14. T.D. Atwell, M.A. Farrell, and M.R. Callstrom et al. Percutaneous cryoablation of large renal masses: technical feasibility and short-term outcome AJR Am J Roentgenol 188 2007 1195 1200
15. T.W. Clark, S.F. Millward, and D.A. Gervais et al. Reporting standards for percutaneous thermal ablation of renal cell carcinoma J Vasc Interv Radiol 20 2009 S409 S416
16. A.I. Mitre, R.F. Coelho, and M. Srougi Pulmonary thromboembolism after renal laparoscopic cryoablation: a case report Clinics (Sao Paulo) 63 2008 289 290
17. Y.S. Tanagho, S.B. Bhayani, E.H. Kim, and R.S. Figenshau Renal cryoablation versus robot-assisted partial nephrectomy: Washington University long-term experience J Endourol 27 2013 1477 1486
18. A. Castro Jr, L.C. Jenkins, N. Salas, G. Lorber, and R.J. Leveillee Ablative therapies for small renal tumours Nat Rev Urol 10 2013 284 291
19. X. Buy, H. Lang, J. Garnon, E. Sauleau, C. Roy, and A. Gangi Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors AJR Am J Roentgenol 201 2013 1353 1361
20. M.H. den Brok, R.P. Sutmuller, and S. Nierkens et al. Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity Br J Cancer 95 2006 896 905
21. M.H. den Brok, R.P. Sutmuller, and S. Nierkens et al. Synergy between in situ cryoablation and TLR9 stimulation results in a highly effective in vivo dendritic cell vaccine Cancer Res 66 2006 7285 7292
22. H.J. Bang, P.J. Littrup, and D.J. Goodrich et al. Percutaneous cryoablation of metastatic renal cell carcinoma for local tumor control: feasibility, outcomes, and estimated cost-effectiveness for palliation J Vasc Interv Radiol 23 2012 770 777
23. H.K. Chew, T. Wun, D. Harvey, H. Zhou, and R.H. White Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 2006 458 464
24. N. Levitan, A. Dowlati, and S.C. Remick et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine (Baltimore) 78 1999 285 291
25. A.Y. Lee, and M.N. Levine Venous thromboembolism and cancer: risks and outcomes Circulation 107 2003 I17 I21